nodes	percent_of_prediction	percent_of_DWPC	metapath
Bedaquiline—Tamoxifen—pancreatic cancer	0.614	1	CrCtD
Bedaquiline—Toremifene—Tamoxifen—pancreatic cancer	0.087	0.292	CrCrCtD
Bedaquiline—Naftifine—Tamoxifen—pancreatic cancer	0.072	0.241	CrCrCtD
Bedaquiline—Bromodiphenhydramine—Tamoxifen—pancreatic cancer	0.0422	0.142	CrCrCtD
Bedaquiline—Clofedanol—Tamoxifen—pancreatic cancer	0.0343	0.115	CrCrCtD
Bedaquiline—Orphenadrine—Tamoxifen—pancreatic cancer	0.0332	0.111	CrCrCtD
Bedaquiline—Diphenhydramine—Tamoxifen—pancreatic cancer	0.0295	0.0989	CrCrCtD
Bedaquiline—CYP3A4—Tamoxifen—pancreatic cancer	0.0113	0.24	CbGbCtD
Bedaquiline—CYP3A4—Erlotinib—pancreatic cancer	0.00964	0.204	CbGbCtD
Bedaquiline—CYP3A4—Irinotecan—pancreatic cancer	0.0087	0.185	CbGbCtD
Bedaquiline—CYP3A4—Docetaxel—pancreatic cancer	0.00638	0.135	CbGbCtD
Bedaquiline—CYP3A4—Sunitinib—pancreatic cancer	0.00635	0.135	CbGbCtD
Bedaquiline—CYP3A4—Doxorubicin—pancreatic cancer	0.00475	0.101	CbGbCtD
Bedaquiline—Septic shock—Sunitinib—pancreatic cancer	0.00182	0.0453	CcSEcCtD
Bedaquiline—Septic shock—Fluorouracil—pancreatic cancer	0.00144	0.0358	CcSEcCtD
Bedaquiline—Amylase increased—Sunitinib—pancreatic cancer	0.00115	0.0288	CcSEcCtD
Bedaquiline—Electrocardiogram QT prolonged—Sunitinib—pancreatic cancer	0.000856	0.0213	CcSEcCtD
Bedaquiline—Torsade de pointes—Sunitinib—pancreatic cancer	0.000783	0.0195	CcSEcCtD
Bedaquiline—Haemoptysis—Sunitinib—pancreatic cancer	0.000742	0.0185	CcSEcCtD
Bedaquiline—Transaminases increased—Gemcitabine—pancreatic cancer	0.000725	0.0181	CcSEcCtD
Bedaquiline—Septic shock—Epirubicin—pancreatic cancer	0.000699	0.0174	CcSEcCtD
Bedaquiline—Septic shock—Doxorubicin—pancreatic cancer	0.000646	0.0161	CcSEcCtD
Bedaquiline—Hepatic function abnormal—Tamoxifen—pancreatic cancer	0.000533	0.0133	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Erlotinib—pancreatic cancer	0.00047	0.0117	CcSEcCtD
Bedaquiline—Hepatic enzyme increased—Gemcitabine—pancreatic cancer	0.000466	0.0116	CcSEcCtD
Bedaquiline—Hepatic function abnormal—Sunitinib—pancreatic cancer	0.000456	0.0114	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Tamoxifen—pancreatic cancer	0.000419	0.0105	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Tamoxifen—pancreatic cancer	0.000411	0.0102	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Sunitinib—pancreatic cancer	0.000407	0.0101	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Erlotinib—pancreatic cancer	0.000406	0.0101	CcSEcCtD
Bedaquiline—Hepatic function abnormal—Gemcitabine—pancreatic cancer	0.000366	0.00913	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Sunitinib—pancreatic cancer	0.000359	0.00895	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Sunitinib—pancreatic cancer	0.000352	0.00877	CcSEcCtD
Bedaquiline—Transaminases increased—Epirubicin—pancreatic cancer	0.000347	0.00865	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Erlotinib—pancreatic cancer	0.000336	0.00837	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Irinotecan—pancreatic cancer	0.000335	0.00836	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Gemcitabine—pancreatic cancer	0.000327	0.00814	CcSEcCtD
Bedaquiline—Hepatitis—Tamoxifen—pancreatic cancer	0.000322	0.00803	CcSEcCtD
Bedaquiline—Transaminases increased—Doxorubicin—pancreatic cancer	0.000321	0.008	CcSEcCtD
Bedaquiline—Hepatitis—Erlotinib—pancreatic cancer	0.000319	0.00794	CcSEcCtD
Bedaquiline—Connective tissue disorder—Erlotinib—pancreatic cancer	0.000313	0.00781	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Irinotecan—pancreatic cancer	0.000296	0.00737	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Sunitinib—pancreatic cancer	0.000291	0.00725	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Gemcitabine—pancreatic cancer	0.000288	0.00718	CcSEcCtD
Bedaquiline—Arrhythmia—Tamoxifen—pancreatic cancer	0.000288	0.00717	CcSEcCtD
Bedaquiline—Haemoptysis—Epirubicin—pancreatic cancer	0.000285	0.00711	CcSEcCtD
Bedaquiline—Arrhythmia—Erlotinib—pancreatic cancer	0.000285	0.0071	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Gemcitabine—pancreatic cancer	0.000282	0.00704	CcSEcCtD
Bedaquiline—Hepatitis—Sunitinib—pancreatic cancer	0.000276	0.00688	CcSEcCtD
Bedaquiline—Connective tissue disorder—Sunitinib—pancreatic cancer	0.000271	0.00676	CcSEcCtD
Bedaquiline—Haemoptysis—Doxorubicin—pancreatic cancer	0.000264	0.00658	CcSEcCtD
Bedaquiline—Cardiac disorder—Sunitinib—pancreatic cancer	0.000256	0.00638	CcSEcCtD
Bedaquiline—Arrhythmia—Sunitinib—pancreatic cancer	0.000246	0.00614	CcSEcCtD
Bedaquiline—Chest pain—Tamoxifen—pancreatic cancer	0.000239	0.00595	CcSEcCtD
Bedaquiline—Myalgia—Tamoxifen—pancreatic cancer	0.000239	0.00595	CcSEcCtD
Bedaquiline—Arthralgia—Tamoxifen—pancreatic cancer	0.000239	0.00595	CcSEcCtD
Bedaquiline—Chest pain—Erlotinib—pancreatic cancer	0.000236	0.00589	CcSEcCtD
Bedaquiline—Myalgia—Erlotinib—pancreatic cancer	0.000236	0.00589	CcSEcCtD
Bedaquiline—Arthralgia—Erlotinib—pancreatic cancer	0.000236	0.00589	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Gemcitabine—pancreatic cancer	0.000233	0.00581	CcSEcCtD
Bedaquiline—Connective tissue disorder—Irinotecan—pancreatic cancer	0.000223	0.00557	CcSEcCtD
Bedaquiline—Nervous system disorder—Erlotinib—pancreatic cancer	0.000222	0.00554	CcSEcCtD
Bedaquiline—Anorexia—Tamoxifen—pancreatic cancer	0.000218	0.00544	CcSEcCtD
Bedaquiline—Connective tissue disorder—Gemcitabine—pancreatic cancer	0.000218	0.00542	CcSEcCtD
Bedaquiline—Anorexia—Erlotinib—pancreatic cancer	0.000216	0.00538	CcSEcCtD
Bedaquiline—Cardiac disorder—Irinotecan—pancreatic cancer	0.000211	0.00526	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000208	0.0052	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000206	0.00514	CcSEcCtD
Bedaquiline—Cardiac disorder—Gemcitabine—pancreatic cancer	0.000205	0.00512	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Docetaxel—pancreatic cancer	0.000204	0.0051	CcSEcCtD
Bedaquiline—Arthralgia—Sunitinib—pancreatic cancer	0.000204	0.0051	CcSEcCtD
Bedaquiline—Chest pain—Sunitinib—pancreatic cancer	0.000204	0.0051	CcSEcCtD
Bedaquiline—Myalgia—Sunitinib—pancreatic cancer	0.000204	0.0051	CcSEcCtD
Bedaquiline—Arrhythmia—Irinotecan—pancreatic cancer	0.000203	0.00506	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Docetaxel—pancreatic cancer	0.0002	0.00499	CcSEcCtD
Bedaquiline—Decreased appetite—Tamoxifen—pancreatic cancer	0.000199	0.00496	CcSEcCtD
Bedaquiline—Arrhythmia—Gemcitabine—pancreatic cancer	0.000198	0.00493	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000198	0.00493	CcSEcCtD
Bedaquiline—Decreased appetite—Erlotinib—pancreatic cancer	0.000197	0.00491	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000195	0.00487	CcSEcCtD
Bedaquiline—Arrhythmia—Fluorouracil—pancreatic cancer	0.000194	0.00485	CcSEcCtD
Bedaquiline—Nervous system disorder—Sunitinib—pancreatic cancer	0.000192	0.00479	CcSEcCtD
Bedaquiline—Anorexia—Sunitinib—pancreatic cancer	0.000187	0.00466	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000179	0.00445	CcSEcCtD
Bedaquiline—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.000175	0.00437	CcSEcCtD
Bedaquiline—Decreased appetite—Sunitinib—pancreatic cancer	0.00017	0.00425	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000169	0.00422	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000165	0.00413	CcSEcCtD
Bedaquiline—Myalgia—Gemcitabine—pancreatic cancer	0.000164	0.00409	CcSEcCtD
Bedaquiline—Chest pain—Gemcitabine—pancreatic cancer	0.000164	0.00409	CcSEcCtD
Bedaquiline—Arthralgia—Gemcitabine—pancreatic cancer	0.000164	0.00409	CcSEcCtD
Bedaquiline—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.000162	0.00404	CcSEcCtD
Bedaquiline—Chest pain—Fluorouracil—pancreatic cancer	0.000161	0.00402	CcSEcCtD
Bedaquiline—Myalgia—Fluorouracil—pancreatic cancer	0.000161	0.00402	CcSEcCtD
Bedaquiline—Nervous system disorder—Irinotecan—pancreatic cancer	0.000158	0.00395	CcSEcCtD
Bedaquiline—Hepatitis—Docetaxel—pancreatic cancer	0.000157	0.00392	CcSEcCtD
Bedaquiline—Diarrhoea—Tamoxifen—pancreatic cancer	0.000157	0.0039	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Epirubicin—pancreatic cancer	0.000156	0.0039	CcSEcCtD
Bedaquiline—Diarrhoea—Erlotinib—pancreatic cancer	0.000155	0.00386	CcSEcCtD
Bedaquiline—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000154	0.00385	CcSEcCtD
Bedaquiline—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000154	0.00384	CcSEcCtD
Bedaquiline—Anorexia—Irinotecan—pancreatic cancer	0.000154	0.00384	CcSEcCtD
Bedaquiline—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000152	0.00378	CcSEcCtD
Bedaquiline—Dizziness—Tamoxifen—pancreatic cancer	0.000151	0.00377	CcSEcCtD
Bedaquiline—Anorexia—Gemcitabine—pancreatic cancer	0.00015	0.00374	CcSEcCtD
Bedaquiline—Dizziness—Erlotinib—pancreatic cancer	0.00015	0.00373	CcSEcCtD
Bedaquiline—Anorexia—Fluorouracil—pancreatic cancer	0.000147	0.00367	CcSEcCtD
Bedaquiline—Cardiac disorder—Docetaxel—pancreatic cancer	0.000146	0.00363	CcSEcCtD
Bedaquiline—Vomiting—Tamoxifen—pancreatic cancer	0.000145	0.00363	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.000145	0.00361	CcSEcCtD
Bedaquiline—Rash—Tamoxifen—pancreatic cancer	0.000144	0.0036	CcSEcCtD
Bedaquiline—Dermatitis—Tamoxifen—pancreatic cancer	0.000144	0.00359	CcSEcCtD
Bedaquiline—Vomiting—Erlotinib—pancreatic cancer	0.000144	0.00359	CcSEcCtD
Bedaquiline—Headache—Tamoxifen—pancreatic cancer	0.000143	0.00357	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000143	0.00357	CcSEcCtD
Bedaquiline—Rash—Erlotinib—pancreatic cancer	0.000143	0.00356	CcSEcCtD
Bedaquiline—Dermatitis—Erlotinib—pancreatic cancer	0.000143	0.00356	CcSEcCtD
Bedaquiline—Headache—Erlotinib—pancreatic cancer	0.000142	0.00354	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000141	0.00351	CcSEcCtD
Bedaquiline—Decreased appetite—Irinotecan—pancreatic cancer	0.00014	0.0035	CcSEcCtD
Bedaquiline—Arrhythmia—Docetaxel—pancreatic cancer	0.00014	0.0035	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000139	0.00347	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000138	0.00344	CcSEcCtD
Bedaquiline—Decreased appetite—Gemcitabine—pancreatic cancer	0.000137	0.00341	CcSEcCtD
Bedaquiline—Nausea—Tamoxifen—pancreatic cancer	0.000136	0.00339	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000136	0.00338	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000135	0.00337	CcSEcCtD
Bedaquiline—Nausea—Erlotinib—pancreatic cancer	0.000134	0.00335	CcSEcCtD
Bedaquiline—Decreased appetite—Fluorouracil—pancreatic cancer	0.000134	0.00335	CcSEcCtD
Bedaquiline—Diarrhoea—Sunitinib—pancreatic cancer	0.000134	0.00334	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000133	0.00333	CcSEcCtD
Bedaquiline—Dizziness—Sunitinib—pancreatic cancer	0.00013	0.00323	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000128	0.00318	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000125	0.00312	CcSEcCtD
Bedaquiline—Vomiting—Sunitinib—pancreatic cancer	0.000125	0.00311	CcSEcCtD
Bedaquiline—Rash—Sunitinib—pancreatic cancer	0.000124	0.00308	CcSEcCtD
Bedaquiline—Dermatitis—Sunitinib—pancreatic cancer	0.000123	0.00308	CcSEcCtD
Bedaquiline—Headache—Sunitinib—pancreatic cancer	0.000123	0.00306	CcSEcCtD
Bedaquiline—Arthralgia—Docetaxel—pancreatic cancer	0.000116	0.0029	CcSEcCtD
Bedaquiline—Chest pain—Docetaxel—pancreatic cancer	0.000116	0.0029	CcSEcCtD
Bedaquiline—Myalgia—Docetaxel—pancreatic cancer	0.000116	0.0029	CcSEcCtD
Bedaquiline—Nausea—Sunitinib—pancreatic cancer	0.000116	0.0029	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000112	0.00278	CcSEcCtD
Bedaquiline—Diarrhoea—Irinotecan—pancreatic cancer	0.00011	0.00275	CcSEcCtD
Bedaquiline—Nervous system disorder—Docetaxel—pancreatic cancer	0.000109	0.00273	CcSEcCtD
Bedaquiline—Diarrhoea—Gemcitabine—pancreatic cancer	0.000108	0.00268	CcSEcCtD
Bedaquiline—Dizziness—Irinotecan—pancreatic cancer	0.000107	0.00266	CcSEcCtD
Bedaquiline—Anorexia—Docetaxel—pancreatic cancer	0.000106	0.00265	CcSEcCtD
Bedaquiline—Hepatitis—Epirubicin—pancreatic cancer	0.000106	0.00264	CcSEcCtD
Bedaquiline—Diarrhoea—Fluorouracil—pancreatic cancer	0.000106	0.00264	CcSEcCtD
Bedaquiline—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000104	0.0026	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000103	0.00257	CcSEcCtD
Bedaquiline—Vomiting—Irinotecan—pancreatic cancer	0.000103	0.00256	CcSEcCtD
Bedaquiline—Dizziness—Fluorouracil—pancreatic cancer	0.000102	0.00255	CcSEcCtD
Bedaquiline—Rash—Irinotecan—pancreatic cancer	0.000102	0.00254	CcSEcCtD
Bedaquiline—Dermatitis—Irinotecan—pancreatic cancer	0.000102	0.00254	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000102	0.00253	CcSEcCtD
Bedaquiline—Headache—Irinotecan—pancreatic cancer	0.000101	0.00252	CcSEcCtD
Bedaquiline—Vomiting—Gemcitabine—pancreatic cancer	0.0001	0.00249	CcSEcCtD
Bedaquiline—Rash—Gemcitabine—pancreatic cancer	9.92e-05	0.00247	CcSEcCtD
Bedaquiline—Dermatitis—Gemcitabine—pancreatic cancer	9.91e-05	0.00247	CcSEcCtD
Bedaquiline—Headache—Gemcitabine—pancreatic cancer	9.85e-05	0.00246	CcSEcCtD
Bedaquiline—Cardiac disorder—Epirubicin—pancreatic cancer	9.83e-05	0.00245	CcSEcCtD
Bedaquiline—Vomiting—Fluorouracil—pancreatic cancer	9.83e-05	0.00245	CcSEcCtD
Bedaquiline—Hepatitis—Doxorubicin—pancreatic cancer	9.8e-05	0.00244	CcSEcCtD
Bedaquiline—Rash—Fluorouracil—pancreatic cancer	9.75e-05	0.00243	CcSEcCtD
Bedaquiline—Dermatitis—Fluorouracil—pancreatic cancer	9.74e-05	0.00243	CcSEcCtD
Bedaquiline—Decreased appetite—Docetaxel—pancreatic cancer	9.7e-05	0.00242	CcSEcCtD
Bedaquiline—Headache—Fluorouracil—pancreatic cancer	9.69e-05	0.00241	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Docetaxel—pancreatic cancer	9.63e-05	0.0024	CcSEcCtD
Bedaquiline—Connective tissue disorder—Doxorubicin—pancreatic cancer	9.63e-05	0.0024	CcSEcCtD
Bedaquiline—Nausea—Irinotecan—pancreatic cancer	9.59e-05	0.00239	CcSEcCtD
Bedaquiline—Arrhythmia—Epirubicin—pancreatic cancer	9.47e-05	0.00236	CcSEcCtD
Bedaquiline—Nausea—Gemcitabine—pancreatic cancer	9.34e-05	0.00233	CcSEcCtD
Bedaquiline—Nausea—Fluorouracil—pancreatic cancer	9.18e-05	0.00229	CcSEcCtD
Bedaquiline—Cardiac disorder—Doxorubicin—pancreatic cancer	9.1e-05	0.00227	CcSEcCtD
Bedaquiline—Arrhythmia—Doxorubicin—pancreatic cancer	8.76e-05	0.00218	CcSEcCtD
Bedaquiline—Arthralgia—Epirubicin—pancreatic cancer	7.85e-05	0.00196	CcSEcCtD
Bedaquiline—Chest pain—Epirubicin—pancreatic cancer	7.85e-05	0.00196	CcSEcCtD
Bedaquiline—Myalgia—Epirubicin—pancreatic cancer	7.85e-05	0.00196	CcSEcCtD
Bedaquiline—Diarrhoea—Docetaxel—pancreatic cancer	7.64e-05	0.0019	CcSEcCtD
Bedaquiline—Nervous system disorder—Epirubicin—pancreatic cancer	7.38e-05	0.00184	CcSEcCtD
Bedaquiline—Dizziness—Docetaxel—pancreatic cancer	7.38e-05	0.00184	CcSEcCtD
Bedaquiline—Chest pain—Doxorubicin—pancreatic cancer	7.27e-05	0.00181	CcSEcCtD
Bedaquiline—Arthralgia—Doxorubicin—pancreatic cancer	7.27e-05	0.00181	CcSEcCtD
Bedaquiline—Myalgia—Doxorubicin—pancreatic cancer	7.27e-05	0.00181	CcSEcCtD
Bedaquiline—Anorexia—Epirubicin—pancreatic cancer	7.18e-05	0.00179	CcSEcCtD
Bedaquiline—Vomiting—Docetaxel—pancreatic cancer	7.1e-05	0.00177	CcSEcCtD
Bedaquiline—Rash—Docetaxel—pancreatic cancer	7.04e-05	0.00175	CcSEcCtD
Bedaquiline—Dermatitis—Docetaxel—pancreatic cancer	7.03e-05	0.00175	CcSEcCtD
Bedaquiline—Headache—Docetaxel—pancreatic cancer	6.99e-05	0.00174	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	6.86e-05	0.00171	CcSEcCtD
Bedaquiline—Nervous system disorder—Doxorubicin—pancreatic cancer	6.83e-05	0.0017	CcSEcCtD
Bedaquiline—Anorexia—Doxorubicin—pancreatic cancer	6.64e-05	0.00166	CcSEcCtD
Bedaquiline—Nausea—Docetaxel—pancreatic cancer	6.63e-05	0.00165	CcSEcCtD
Bedaquiline—Decreased appetite—Epirubicin—pancreatic cancer	6.54e-05	0.00163	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Epirubicin—pancreatic cancer	6.5e-05	0.00162	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	6.35e-05	0.00158	CcSEcCtD
Bedaquiline—Decreased appetite—Doxorubicin—pancreatic cancer	6.05e-05	0.00151	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	6.01e-05	0.0015	CcSEcCtD
Bedaquiline—Diarrhoea—Epirubicin—pancreatic cancer	5.15e-05	0.00128	CcSEcCtD
Bedaquiline—Dizziness—Epirubicin—pancreatic cancer	4.98e-05	0.00124	CcSEcCtD
Bedaquiline—Vomiting—Epirubicin—pancreatic cancer	4.79e-05	0.00119	CcSEcCtD
Bedaquiline—Diarrhoea—Doxorubicin—pancreatic cancer	4.77e-05	0.00119	CcSEcCtD
Bedaquiline—Rash—Epirubicin—pancreatic cancer	4.75e-05	0.00118	CcSEcCtD
Bedaquiline—Dermatitis—Epirubicin—pancreatic cancer	4.74e-05	0.00118	CcSEcCtD
Bedaquiline—Headache—Epirubicin—pancreatic cancer	4.72e-05	0.00118	CcSEcCtD
Bedaquiline—Dizziness—Doxorubicin—pancreatic cancer	4.61e-05	0.00115	CcSEcCtD
Bedaquiline—Nausea—Epirubicin—pancreatic cancer	4.47e-05	0.00111	CcSEcCtD
Bedaquiline—Vomiting—Doxorubicin—pancreatic cancer	4.43e-05	0.0011	CcSEcCtD
Bedaquiline—Rash—Doxorubicin—pancreatic cancer	4.39e-05	0.00109	CcSEcCtD
Bedaquiline—Dermatitis—Doxorubicin—pancreatic cancer	4.39e-05	0.00109	CcSEcCtD
Bedaquiline—Headache—Doxorubicin—pancreatic cancer	4.36e-05	0.00109	CcSEcCtD
Bedaquiline—Nausea—Doxorubicin—pancreatic cancer	4.14e-05	0.00103	CcSEcCtD
